Skip to content
10-K

Annual Report

QLY BIOTECH GROUP CORP.

0001477932-22-009289

← back to feed
Filed
Dec 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Dec 14, 2022 3.9M sh
Operating Cash Flow FY 2022 · Aug 31, 2022 −$14.21K
Operating Cash Flow FY 2022 · Aug 31, 2021 −$26.27K
Cash And Equivalents FY 2022 · Aug 31, 2022 $0
Cash And Equivalents FY 2022 · Aug 31, 2021 $5.17K
Stockholders Equity FY 2022 · Aug 31, 2022 $0
Stockholders Equity FY 2022 · Aug 31, 2021 −$5.96K
Stockholders Equity FY 2022 · Aug 31, 2020 $23.54K
Current Liabilities FY 2022 · Aug 31, 2022 $0
Current Liabilities FY 2022 · Aug 31, 2021 $13.12K
Total Liabilities FY 2022 · Aug 31, 2022 $0
Total Liabilities FY 2022 · Aug 31, 2021 $13.12K
Current Assets FY 2022 · Aug 31, 2022 $0
Current Assets FY 2022 · Aug 31, 2021 $5.17K
Total Assets FY 2022 · Aug 31, 2022 $0
Total Assets FY 2022 · Aug 31, 2021 $7.16K
Sga Expense FY 2022 · Aug 31, 2022 $14.11K
Sga Expense FY 2022 · Aug 31, 2021 $32.1K
Net Income FY 2022 · Aug 31, 2022 −$14.11K
Net Income FY 2022 · Aug 31, 2021 −$29.5K
Operating Income FY 2022 · Aug 31, 2022 $14.11K
Gross Profit FY 2022 · Aug 31, 2022 $0
Gross Profit FY 2022 · Aug 31, 2021 $2.6K
Cost Of Revenue FY 2022 · Aug 31, 2022 $0
Cost Of Revenue FY 2022 · Aug 31, 2021 $1.4K
Revenue FY 2022 · Aug 31, 2022 $0
Revenue FY 2022 · Aug 31, 2021 $4K